BridgeBio Pharma Stock Target Price and Analyst Consensus
| BBIO Stock | USD 28.54 0.77 2.77% |
The current analyst and expert consensus on BridgeBio Pharma is Strong Buy with 6 buy recommendations. The current projected BridgeBio Pharma target price consensus is 46.40, with 17 analyst opinions. BridgeBio Pharma buy-or-sell recommendation module provides average expert sentiment on the projected BridgeBio Pharma target price to derive its highest and lowest estimates based on target price estimated volatility of 3.6436. Check out Macroaxis Advice on BridgeBio Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in BridgeBio Stock, please use our How to Invest in BridgeBio Pharma guide.
Lowest Forecast 42.22 | Highest Forecast 51.5 | Target Price 46.4 |
BridgeBio |
It's important to approach BridgeBio Pharma's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize BridgeBio Pharma price targets
BridgeBio Pharma's stock target price is an estimate of its future price, usually made by analysts. Using BridgeBio Pharma's target price to determine if it is a suitable investment can be done through the following steps:- Look at BridgeBio Pharma's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if BridgeBio Pharma's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional BridgeBio Pharma Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of BridgeBio Pharma is a key component of BridgeBio Pharma valuation and have some predictive power on the future returns of a BridgeBio Pharma.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Banking Invested over 40 shares | |
 | Dividend Beast Invested over 50 shares | |
 | Driverless Cars Invested over 200 shares | |
 | Momentum Invested over 50 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Investor Favorites Invested over 40 shares | |
 | Social Domain Invested few shares | |
 | Impulse Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Blockchain Invested few shares | |
 | Technology Invested few shares | |
 | Millennials Best Invested few shares | |
Check out Macroaxis Advice on BridgeBio Pharma to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. To learn how to invest in BridgeBio Stock, please use our How to Invest in BridgeBio Pharma guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.